Assessing Structure Therapeutics (GPCR) Valuation After Positive Phase 2 Data And Large Capital Raise

Structure Therapeutics (GPCR) has been in focus after reporting positive phase 2 results for its oral weight loss candidate ...
Fintel on MSN

Structure Therapeutics Inc. - Depositary Receipt (GPCR) price target increased by 10.08% to 103.82

The average one-year price target for Structure Therapeutics Inc. - Depositary Receipt (NasdaqGM:GPCR) has been revised to ...
American Association of Individual Investors

Why Structure Therapeutics Inc.’s (GPCR) Stock Is Up 6.29%

As of Tuesday, January 13, Structure Therapeutics Inc.’s GPCR share price has surged by 6.29%, which has investors ...

Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies

Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies -- Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of ...

HC Wainwright upgrades Structure Therapeutics (GPCR) on massive arbitrage opportunity for oral GLP-1

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best up and coming stocks to buy according to Wall Street. On ...
Business Wire

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR ...